arsenic trioxide has been researched along with Shingles in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, J; Freyer, CW; Luger, SM; Man, Y; Peterson, CE; Przespolewski, A | 1 |
| Ahr, K; Derkach, A; Douer, D; Glass, JL; Hilden, P; King, A; Kishtagari, A; Levine, RL; Seo, SK; Tallman, MS | 1 |
| Matsue, K; Nisihida, Y; Sugihara, H; Takeuchi, M; Tsuda, K; Ugai, T; Yamakura, M | 1 |
| Lanska, DJ | 1 |
| Nand, S; Tanvetyanon, T | 1 |
| Au, WY; Kwong, YL | 1 |
| Ahn, E; Bach, A; Bouzari, N; Chen, H; Nouri, K; Ricotti, CA | 1 |
7 other study(ies) available for arsenic trioxide and Shingles
| Article | Year |
|---|---|
Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Herpes Zoster; Humans; Leukemia, Promyelocytic, Acute; Oxides; Tretinoin | 2021 |
Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.
Topics: Antineoplastic Agents; Arsenic Trioxide; Disease Susceptibility; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunosuppressive Agents; Leukemia, Promyelocytic, Acute; Retrospective Studies; Virus Activation | 2021 |
High frequency of varicella zoster virus reactivation associated with the use of arsenic trioxide in patients with acute promyelocytic leukemia.
Topics: Acyclovir; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Incidence; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Retrospective Studies; Valacyclovir; Valine; Virus Activation | 2014 |
Herpes zoster during treatment with arsenic trioxide.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Herpes Zoster; Humans; Leukemia, Promyelocytic, Acute; Oxides | 2004 |
Herpes zoster during treatment with arsenic trioxide.
Topics: 2-Aminopurine; Antineoplastic Agents; Antiviral Agents; Arsenic Trioxide; Arsenicals; Famciclovir; Female; Herpes Zoster; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Treatment Outcome | 2004 |
Frequent varicella zoster reactivation associated with therapeutic use of arsenic trioxide: portents of an old scourge.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Chickenpox; Child; Female; Herpes Zoster; Humans; Male; Middle Aged; Oxides; Recurrence | 2005 |
The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide.
Topics: Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Colonic Neoplasms; Female; Herpes Simplex; Herpes Zoster; Humans; Male; Multiple Myeloma; Oxides; Recurrence | 2006 |